Towards Healthcare Research & Consulting

SEARCH RESULT FOR

GLP-1 Receptor Agonist

July 16, 2026

GLP-1 Receptor Agonist Market Growth, Demand, and Production Forecast 2035

  • Status : Published
  • No. of Pages: 150+
  • Category : Therapeutic Area

The GLP-1 receptor agonist market size is calculated at $62.86 bn in 2025 is to hit USD 315.33 bn by 2035. GLP-1 receptor agonists are peptide drugs that mimic the GLP-1 hormone to lower blood glucose and aid weight loss. With rising diabetes and obe...

April 21, 2026

GLP-1 Small Molecule Market Evolution Across Metabolic Care

  • Status : Published
  • No. of Pages: 150+
  • Category : Therapeutic Area

The GLP-1 small molecule market covers comprehensive insights on global market size, segmentation, regional performance, and competitive dynamics across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market ...

April 06, 2026

Oral GLP-1 Market accelerates innovation in weight loss solutions

  • Status : Published
  • No. of Pages: 150+
  • Category : Therapeutic Area

Oral GLP-1 Market (By Drug Type: Oral Peptide GLP-1 Agonists, Small-Molecule Non-Peptide GLP-1 Agonists; By Molecule: Semaglutide, Danuglipron, Orforglipron, Lotiglipron, Other Emerging Candidates; By Distribution Channel: Hospital & Special...

July 17, 2026

GLP-1 Drugs Market Growth, Innovations, and Market Size Forecast 2035

  • Status : Published
  • No. of Pages: 150+
  • Category : Therapeutic Area

According to market projections, the GLP-1 drugs sector is expected to grow from USD 52.95 billion in 2025 to USD 132.79 billion by 2035, reflecting a CAGR of 9.63%. The GLP-1 drugs market is expanding due to increasing incidences of type 2 diabetes ...

April 21, 2026

Peptide Receptor Radionuclide Therapy Market Compliance, Approvals and Dynamics

  • Status : Published
  • No. of Pages: 150+
  • Category : Therapeutic Area

According to forecasts, the global peptide receptor radionuclide therapy market will grow from USD 2.34 billion in 2024 to USD 6.1 billion by 2034, with an expected CAGR of 10.06%. In 2024, North America led the global peptide receptor radionuclide t...

April 21, 2026

Oral Thrombopoietin Receptor Agonists Market Driven by FDA Approvals & Chronic Liver Disease Burden

  • Status : Published
  • No. of Pages: 150+
  • Category : Therapeutic Area

According to market forecast, the global oral thrombopoietin receptor agonists market is projected to reach US$ 9.95 billion by 2034, driven by rising cases of thrombocytopenia and advancements in TPO-RAs. North America leads, while Asia-Pacific show...

April 21, 2026

Thrombopoietin Receptor Agonists Market 2025 Growth Accelerates with Pediatric Drug Launches and Global Clinical Trials

  • Status : Published
  • No. of Pages: 150+
  • Category : Therapeutic Area

According to market estimations, the global thrombopoietin receptor agonists industry, valued at US$ 1.85 billion in 2023, is set to reach US$ 3.74 billion by 2034, driven by rising platelet-related disorders like ITP and AML. Key trends include FD...

July 01, 2026

G-Protein Coupled Receptors Market Report: Size, Growth and Outlook

  • Status : Published
  • No. of Pages: 150+
  • Category : Therapeutic Area

According to Shivani Zoting, who specializes in biotechnology, pharmaceutical research, and life sciences, with 5+ years of experience in market research and industry analysis, the G-Protein Coupled Receptors (GPCR) market is set to grow from USD 4.2...